PH27534A - Antoganists of gm-csf derived from the carboxyl terminus - Google Patents

Antoganists of gm-csf derived from the carboxyl terminus

Info

Publication number
PH27534A
PH27534A PH40830A PH40830A PH27534A PH 27534 A PH27534 A PH 27534A PH 40830 A PH40830 A PH 40830A PH 40830 A PH40830 A PH 40830A PH 27534 A PH27534 A PH 27534A
Authority
PH
Philippines
Prior art keywords
antoganists
carboxyl terminus
csf derived
csf
derived
Prior art date
Application number
PH40830A
Other languages
English (en)
Inventor
Gail Foure Seelig
Julie Ellen Scheffler
Paul Phillip Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PH27534A publication Critical patent/PH27534A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH40830A 1989-07-14 1990-07-12 Antoganists of gm-csf derived from the carboxyl terminus PH27534A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37984689A 1989-08-14 1989-08-14

Publications (1)

Publication Number Publication Date
PH27534A true PH27534A (en) 1993-08-18

Family

ID=23498958

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40830A PH27534A (en) 1989-07-14 1990-07-12 Antoganists of gm-csf derived from the carboxyl terminus

Country Status (16)

Country Link
US (1) US5475087A (xx)
EP (2) EP0482086A1 (xx)
JP (1) JPH04503815A (xx)
KR (1) KR920701246A (xx)
AU (1) AU630496B2 (xx)
CA (1) CA2062975A1 (xx)
FI (1) FI920150A0 (xx)
HU (1) HUT63181A (xx)
IE (1) IE902562A1 (xx)
IL (1) IL95061A0 (xx)
MY (1) MY105946A (xx)
NO (1) NO920176L (xx)
NZ (1) NZ234479A (xx)
PH (1) PH27534A (xx)
WO (1) WO1991001330A1 (xx)
ZA (1) ZA905480B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060741A1 (en) * 1991-02-11 1992-08-12 Robert S. Greenfield Gm-csf inhibiting oligopeptides
CA2149881A1 (en) * 1992-11-19 1994-05-26 Paul T. Jubinsky Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) * 1995-02-08 1997-07-11 Stephanois Rech Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) * 1995-06-23 1995-07-20 Bresagen Limited Haemopoietic growth factor antagonists and uses therefor
US8062637B2 (en) * 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
AU2005100402B4 (en) * 2005-05-16 2006-01-12 Novomatic Ag Method for increased chances at an award on a Gaming Machine
AU2013201228B2 (en) * 2006-02-08 2016-01-21 Eisai, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
US7741450B2 (en) 2006-02-08 2010-06-22 Morphotek Inc. Antibodies to GM-CSF
US8398972B2 (en) 2006-11-21 2013-03-19 Kalobios Pharmaceuticals, Inc. Methods of treating dementia using a GM-CSF antagonist
KR101517251B1 (ko) * 2006-11-21 2015-05-07 칼로바이오스 파마슈티컬스, 아이엔씨. Ｇｍ-ｃｓｆ 길항제를 사용한 만성 염증성 질환의 치료 방법
TW200918553A (en) * 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
CN104072613A (zh) 2007-11-13 2014-10-01 Evec股份有限公司 与hGM-CSF结合的单克隆抗体及包含它的药物组合物
CN106397591A (zh) 2008-12-22 2017-02-15 墨尔本大学 骨关节炎治疗
WO2010071923A1 (en) * 2008-12-22 2010-07-01 The University Of Melbourne Pain treatment
WO2013026059A1 (en) 2011-08-18 2013-02-21 New York University Inhibition of oncogenic kras-induced gm-csf production and function
WO2013072901A2 (en) * 2011-11-17 2013-05-23 Btm Mazowsze Sp. Zo.O. Compositions and methods for treating glioma
US20240227257A9 (en) 2021-02-15 2024-07-11 Splifar S.A. Method for applying a seal to a plate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
NZ228031A (en) * 1984-07-06 1991-12-23 Sandoz Ltd Primate gm-csf and method of extraction
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
CA2062975A1 (en) 1991-01-15
NZ234479A (en) 1992-03-26
MY105946A (en) 1995-02-28
NO920176D0 (no) 1992-01-14
EP0409091A1 (en) 1991-01-23
FI920150A0 (fi) 1992-01-14
HUT63181A (en) 1993-07-28
ZA905480B (en) 1991-03-27
NO920176L (no) 1992-01-14
IL95061A0 (en) 1991-06-10
HU9200087D0 (en) 1992-04-28
IE902562A1 (en) 1991-02-27
KR920701246A (ko) 1992-08-11
AU6148790A (en) 1991-02-22
AU630496B2 (en) 1992-10-29
EP0482086A1 (en) 1992-04-29
WO1991001330A1 (en) 1991-02-07
JPH04503815A (ja) 1992-07-09
US5475087A (en) 1995-12-12

Similar Documents

Publication Publication Date Title
PH27534A (en) Antoganists of gm-csf derived from the carboxyl terminus
EP0417959A3 (en) An assembly for locating the position of an object
IL94699A0 (en) Imidazolyl-alkenoic acids
GB2215150B (en) Signal conditioners
ZA902510B (en) 5-alkylquinolonecarboxylic acids
GB2230835B (en) Pipe flange connections
AU3001884A (en) Spraying refractory
YU39388A (en) Flange connection
IL96475A0 (en) Chimeric proteins
AU631399B2 (en) Novel novolaks of the phenol-dense aldehyde type
AU6903591A (en) Point of sale system
GB8925298D0 (en) Object tracking
AU591459B2 (en) cDNA probe for the detection of bluetongue virus
GB8717072D0 (en) Induction-type compressor
EP0430866A3 (en) Connection piece
AU544840B2 (en) Selection stage of the ac signal having the greater amplitude
GB8924829D0 (en) Object tracking
IL85803A (en) Gimbal assembly
AU6722190A (en) Fluid-containment vessel
GB2249072B (en) Point of sale arrangement
ZA907896B (en) Substituted acrylamido-penicillanic esters
ZA887993B (en) The tracking of objects
BG47918A1 (en) Isolated analogous signal adapter
IL106072A0 (en) Intermediates for the preparation of 4-aminoquinolines
GB8907660D0 (en) Polypeptide